GeoVax Net Debt from 2010 to 2025

GOVXW Stock

USD 0.13 0 3.77%

GeoVax Labs Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of GeoVax Labs minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2000-03-31

Previous Quarter

-1.4 M

Current Value

-8.6 M

Quarterly Volatility

7.5 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check GeoVax Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GeoVax Labs' main balance sheet or income statement drivers, such as Depreciation And Amortization of 63.4 K, Interest Expense of 48.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 324, Dividend Yield of 0.0 or PTB Ratio of 2.61. GeoVax financial statements analysis is a perfect complement when working with GeoVax Labs Valuation or Volatility modules.

Check out the analysis of GeoVax Labs Correlation against competitors.

For more information on how to buy GeoVax Stock please use our How to Invest in GeoVax Labs guide.

Latest GeoVax Labs' Net Debt Growth Pattern

Below is the plot of the Net Debt of GeoVax Labs over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. GeoVax Labs' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GeoVax Labs' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

GeoVax Net Debt Regression Statistics

	Arithmetic Mean	(4,609,358)
	Coefficient Of Variation	(154.67)
	Mean Deviation	4,855,459
	Median	(1,022,734)
	Standard Deviation	7,129,284
	Sample Variance	50.8T
	Range	27.7M
	R-Value	(0.54)
	Mean Square Error	38.6T
	R-Squared	0.29
	Significance	0.03
	Slope	(807,473)
	Total Sum of Squares	762.4T

GeoVax Net Debt History

	2025	-5.5 M
	2024	-5.8 M
	2023	-6.5 M
	2022	-27.6 M
	2021	-11.4 M
	2020	-9.7 M
	2019	-243.6 K

Other Fundumenentals of GeoVax Labs

Net Debt To E B I T D A

GeoVax Labs Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Common Stock	Good Will	Short Term Debt	Current Deferred Revenue	Intangible Assets	Capital Surpluse	Property Plant Equipment	Net Invested Capital	Net Working Capital	Long Term Debt	Short Long Term Debt	Capital Stock
Total Assets		0.97	-0.98	-0.65	0.6	-0.26	0.66	1.0	-0.3	0.15	-0.27	0.1	-0.13	0.73	0.75	0.98	0.98	-0.76	-0.31	-0.78
Total Stockholder Equity	0.97		-0.96	-0.53	0.46	-0.18	0.48	0.97	-0.28	0.08	-0.19	0.05	-0.08	0.63	0.66	0.98	0.98	-0.64	-0.2	-0.67
Net Debt	-0.98	-0.96		0.55	-0.47	0.19	-0.66	-0.99	0.27	-0.16	0.22	-0.16	0.2	-0.69	-0.66	-0.97	-0.98	0.71	0.26	0.72
Retained Earnings	-0.65	-0.53	0.55		-0.94	0.44	-0.7	-0.62	0.27	-0.43	0.41	-0.31	0.36	-0.83	-0.81	-0.64	-0.57	0.85	0.53	0.88
Accounts Payable	0.6	0.46	-0.47	-0.94		-0.43	0.69	0.57	-0.38	0.35	-0.37	0.18	-0.2	0.77	0.86	0.55	0.49	-0.78	-0.46	-0.85
Net Receivables	-0.26	-0.18	0.19	0.44	-0.43		-0.38	-0.25	0.02	0.24	0.38	0.32	-0.23	-0.26	-0.24	-0.2	-0.19	0.28	0.28	0.28
Total Liab	0.66	0.48	-0.66	-0.7	0.69	-0.38		0.67	-0.21	0.24	-0.4	0.25	-0.23	0.78	0.62	0.58	0.58	-0.78	-0.44	-0.75
Total Current Assets	1.0	0.97	-0.99	-0.62	0.57	-0.25	0.67		-0.3	0.13	-0.27	0.09	-0.13	0.73	0.73	0.98	0.99	-0.75	-0.3	-0.77
Common Stock	-0.3	-0.28	0.27	0.27	-0.38	0.02	-0.21	-0.3		-0.05	0.43	0.01	-0.04	-0.37	-0.53	-0.27	-0.26	0.46	0.43	0.43
Good Will	0.15	0.08	-0.16	-0.43	0.35	0.24	0.24	0.13	-0.05		0.06	0.93	-0.95	0.29	0.29	0.2	0.18	-0.31	-0.28	-0.33
Short Term Debt	-0.27	-0.19	0.22	0.41	-0.37	0.38	-0.4	-0.27	0.43	0.06		0.13	-0.09	-0.42	-0.25	-0.24	-0.22	0.57	0.94	0.43
Current Deferred Revenue	0.1	0.05	-0.16	-0.31	0.18	0.32	0.25	0.09	0.01	0.93	0.13		-0.95	0.31	0.16	0.16	0.13	-0.26	-0.17	-0.22
Intangible Assets	-0.13	-0.08	0.2	0.36	-0.2	-0.23	-0.23	-0.13	-0.04	-0.95	-0.09	-0.95		-0.26	-0.18	-0.19	-0.18	0.28	0.24	0.26
Capital Surpluse	0.73	0.63	-0.69	-0.83	0.77	-0.26	0.78	0.73	-0.37	0.29	-0.42	0.31	-0.26		0.86	0.74	0.69	-0.96	-0.47	-0.94
Property Plant Equipment	0.75	0.66	-0.66	-0.81	0.86	-0.24	0.62	0.73	-0.53	0.29	-0.25	0.16	-0.18	0.86		0.73	0.7	-0.87	-0.34	-0.95
Net Invested Capital	0.98	0.98	-0.97	-0.64	0.55	-0.2	0.58	0.98	-0.27	0.2	-0.24	0.16	-0.19	0.74	0.73		0.99	-0.75	-0.3	-0.78
Net Working Capital	0.98	0.98	-0.98	-0.57	0.49	-0.19	0.58	0.99	-0.26	0.18	-0.22	0.13	-0.18	0.69	0.7	0.99		-0.72	-0.28	-0.74
Long Term Debt	-0.76	-0.64	0.71	0.85	-0.78	0.28	-0.78	-0.75	0.46	-0.31	0.57	-0.26	0.28	-0.96	-0.87	-0.75	-0.72		0.64	0.97
Short Long Term Debt	-0.31	-0.2	0.26	0.53	-0.46	0.28	-0.44	-0.3	0.43	-0.28	0.94	-0.17	0.24	-0.47	-0.34	-0.3	-0.28	0.64		0.52
Capital Stock	-0.78	-0.67	0.72	0.88	-0.85	0.28	-0.75	-0.77	0.43	-0.33	0.43	-0.22	0.26	-0.94	-0.95	-0.78	-0.74	0.97	0.52

Click cells to compare fundamentals

About GeoVax Labs Financial Statements

GeoVax Labs investors use historical fundamental indicators, such as GeoVax Labs' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in GeoVax Labs. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	-5.8 M	-5.5 M
Net Debt To EBITDA	0.22	0.26

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for GeoVax Stock Analysis

When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

GeoVax Net Debt from 2010 to 2025

Latest GeoVax Labs' Net Debt Growth Pattern

GeoVax Net Debt Regression Statistics

GeoVax Net Debt History

Other Fundumenentals of GeoVax Labs

GeoVax Labs Net Debt component correlations

About GeoVax Labs Financial Statements

Also Currently Popular

Additional Tools for GeoVax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY